It was only when she started tackling her specific obesity drivers that Olson began losing lots of weight 65 pounds to date, as she remains on the medicine
The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications
For further questions or comments regarding how we handle your personal data, you can always contact us, either by email at [email protected] or by mail to any of the aforementioned postal addresses
Data Extraction and Quality Assessment Two investigators (Hu and Song) independently extracted the following data by reviewing the full text of each study: first author, year of publication, Clinical Trial Registration Number (NCT ID), trial duration, patient characteristics, sample size, intervention (type of GLP-1 receptor agonist), comparators, and outcomes of interest
As the founder of the Modern Thyroid Clinic, I have witnessed firsthand how these medications can transform lives, particularly for individuals struggling with weight loss due to underlying health conditions
